Nordhealth AS
The answer first
Does Nordhealth beat the market?
No, Nordhealth has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 34% of Nordic stocks
- Quality64
- Value13
- Trend54
No. 95 of 195 in healthcare
Max for seven days
Follow Nordhealth with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Nordhealth
Your first answer is free, no account needed.
Do you own Nordhealth, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Nordhealth and a few more. Free, no card.
Super Stock+45.3%In short
- Nordhealth has fallen 11.8% over the past year, including dividends.
- Overall, Nordhealth ranks better than 34% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 52.3%. The price is 41.7% below its peak now.
What do analysts think of Nordhealth?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 34% of Nordic stocks.
No. 95 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 99 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.82
- Return on equityProfit divided by equity−29.0%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 124 of 197 in healthcareTypical in healthcare: 19Typical in the Nordics: 50
- P/BPrice divided by equity3.5
- P/SPrice divided by sales3.4
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 70 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+9.8%
- 6 months−4.3%
- 9 months−10.7%
- 12 months−11.8%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Nordhealth
One fund we follow owns Nordhealth. The share is how much of the fund the stock makes up.
- Norway1
From the funds' latest known holdings.
About Nordhealth
Nordhealth AS is a company in healthcare, listed on Oslo Børs. By market value, Nordhealth is number 3 of 23 companies in healthcare on Oslo Børs. Nordhealth has not paid a dividend in the past twelve months. Of the three measures in the ranking, Nordhealth is strongest on quality, better than 64% of Nordic stocks. The next report from Nordhealth is expected on 2 March 2027. The share trades in NOK. It has around 400 employees.
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally. Its products include Provet, a practice management software platform for veterinary clinics and enterprise groups, providing appointment scheduling, patient management, electronic health records, billing and invoicing, reporting and analytics, government compliance tools, communication features, inventory management, and workflow automation; Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychiatrists; EasyPractice, a PMS for therapists; and…


See the full analysis of Nordhealth.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card